COR (US) share price forecast & AI signal — Cencora, Inc
Week of 2026-10-30 · Healthcare
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in COR
Cencora, Inc is a Healthcare stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a HOLD with low confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About Cencora, Inc
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to...
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $333.56 |
| 2026-11-05 | $339.68 |
| 2026-11-04 | $354.00 |
| 2026-11-03 | $340.50 |
| 2026-11-02 | $337.84 |
| 2026-10-30 | $330.84 |
| 2026-10-29 | $330.53 |
COR FAQ
Is Cencora, Inc (COR) a buy or sell this week?
The ACE Stock Bots machine-learning model rates COR a HOLD for the week of 2026-10-30 with low confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for COR?
Every week the model scores COR across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Healthcare stocks on the US
This week's top US picks · All US stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.